Notice of Intent to Publish a Funding Opportunity Announcement for Trailblazer Award for New and Early-Stage Investigators (R21 Clinical Trial Optional)
This grant funds innovative research projects led by new and early-stage investigators.
About this program
The Trailblazer Award is designed to support new and early-stage investigators in conducting innovative research that has the potential to advance scientific knowledge and improve health outcomes. This funding opportunity encourages novel approaches and methodologies in research, allowing investigators to explore untested ideas and concepts. The program aims to foster the development of a diverse pool of researchers who can contribute to the scientific community and address pressing health challenges. Eligible applicants include new and early-stage investigators who are affiliated with eligible institutions. The grant provides funding for projects that demonstrate a clear potential for significant impact in their respective fields. By supporting these investigators, the Trailblazer Award seeks to cultivate a new generation of researchers who can lead transformative studies and contribute to the advancement of science and healthcare.
Eligibility
New and early-stage investigators affiliated with eligible institutions.